Our studies have concerned regulation of gene expression during normal and abnormal differentiation processes. Hybridization and nuclease S1 mapping analysis demonstrated that 20S mature a-fetoprotein (AFP) and the 16S variant AFP mRNAS differ in sequences at the 5' end. The first six exons of the 20S mRNA were missing in the 16S RNA. We demonstrated that glucocorticoid hormone promotes matuation of fetal hepatocytes in vitro. Administration of glucocorticoid to differentiated fetal hepatocytes inhibited the production of fetal protein, AFP but induced the synthesis of tyrosine aminotransferase (TAT), an enzyme which appears only postnatally. Therefore, fetal cells matured into adult hepatocytes in the presence of glucocorticoid. The ts adult hepatocyte line expressed a large number of liver-specific functions. In addition to synthesizing AFP, albumin, and transferrin, these cells expressed genes encoding TAT, phosphoenolpyruvate carboxykinase (PEPCK), and fibrinogen. Furthermore, we showed that the expression of these genes was ts and glucocorticoid dependent. Genes encoding placental alkaline phosphatase (PAP) subunits were cloned. We found both choriocarcinoma and HeLa cells expressed different-sized PAP mRNA. Prednisolone and sodium butyrate which increased PAP biosynthesis in HeLa cells induced the expression of mature PAP mRNA. We cloned genes encoding pregnancy-specific Beta-1-glycoprotein (PSBetaG). These probes are used to examine molecular mechanism regulating PSBetaG synthesis in placental cells and fibroblasts.

Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1986
Total Cost
Indirect Cost
Name
U.S. National Inst/Child Hlth/Human Dev
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Cho, Jun-Ho; Kim, Goo-Young; Mansfield, Brian C et al. (2018) Hepatic glucose-6-phosphatase-? deficiency leads to metabolic reprogramming in glycogen storage disease type Ia. Biochem Biophys Res Commun 498:925-931
Yiu, W H; Pan, C-J; Allamarvdasht, M et al. (2007) Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice. Gene Ther 14:219-26
Cheung, Yuk Yin; Kim, So Youn; Yiu, Wai Han et al. (2007) Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta. J Clin Invest 117:784-93
Chou, Janice Y; Mansfield, Brian C (2007) Gene therapy for type I glycogen storage diseases. Curr Gene Ther 7:79-88
Kim, So Youn; Chen, Li-Yuan; Yiu, Wai Han et al. (2007) Neutrophilia and elevated serum cytokines are implicated in glycogen storage disease type Ia. FEBS Lett 581:3833-8
Walker, Elizabeth A; Ahmed, Adeeba; Lavery, Gareth G et al. (2007) 11beta-Hydroxysteroid Dehydrogenase Type 1 Regulation by Intracellular Glucose 6-Phosphate Provides Evidence for a Novel Link between Glucose Metabolism and Hypothalamo-Pituitary-Adrenal Axis Function. J Biol Chem 282:27030-6
Ghosh, A; Allamarvdasht, M; Pan, C-J et al. (2006) Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer. Gene Ther 13:321-9
Nguyen, Andrew D; Pan, Chi-Jiunn; Weinstein, David A et al. (2006) Increased scavenger receptor class B type I-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type Ia patients. Mol Genet Metab 89:233-8
Kim, So Youn; Nguyen, Andrew D; Gao, Ji-Liang et al. (2006) Bone marrow-derived cells require a functional glucose 6-phosphate transporter for normal myeloid functions. J Biol Chem 281:28794-801
Ghosh, Abhijit; Cheung, Yuk Yin; Mansfield, Brian C et al. (2005) Brain contains a functional glucose-6-phosphatase complex capable of endogenous glucose production. J Biol Chem 280:11114-9

Showing the most recent 10 out of 40 publications